CDNA Stock Analysis: Buy, Sell, or Hold?
CDNA - CareDx, Inc.
$25.34
0.29 (1.16%)
▲
5d:
+5.23%
30d:
+17.48%
90d:
+44.31%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 05, 2026
Get Alerted When CDNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: CDNA is 7.6% above its trading range ($23.56). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: CDNA is 7.6% above its trading range ($23.56). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$40.31
Based on 12.7% avg growth
INTRINSIC VALUE TODAY
$25.03
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CDNA is currently trading at $25.34, which is considered extended relative to its 30-day fair value range of $20.95 to $23.56. From a valuation perspective, the stock is trading at a premium (Forward PE: 22.1) compared to its historical average (19.7). At these levels, the market is pricing in 3.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CDNA is in a strong downtrend. Immediate support is located at $21.62, while resistance sits at $26.78.
Market Sentiment: CDNA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CDNA is in a strong downtrend. Immediate support is located at $21.62, while resistance sits at $26.78.
Market Sentiment: CDNA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$20.95 -
$23.56
Company Quality Score
68/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
53.3%
Protect Your Profits
Holding CDNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.6% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($25.80)
- NEUTRAL: Market pricing in 3.8% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$20.95 -
$23.56
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$21.62
Resistance Level
$26.78
Current Trend
Strong Downtrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.09
Wall Street Target
$25.80
(+3.0%)
Revenue Growth (YoY)
39.0%
Profit Margin
-2.0%
Valuation Premium vs History
+3.8% premium
PE vs Historical
22.1 vs 19.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.8%
(market-implied from PE analysis)
1-Year Target
$26.00
(+4%)
2-Year Target
$26.99
(+8%)
3-Year Target
$28.02
(+12%)
3-Yr Target (if PE normalizes)
(PE: 22→20)
PE COMPRESSION
$24.98
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 21.4%)
$44.83
(+79%)
Base:
(SPY PE: 21.8, Growth: 21.4%)
$44.20
(+77%)
Bear:
(PE: 18.5, Growth: 21.4%)
$37.57
(+50%)
Share & Embed Analysis
Last updated: June 23, 2026 10:39 AM ET
Data refreshes hourly during market hours. Next update: 11:39 AM
Data refreshes hourly during market hours. Next update: 11:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CDNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
John Walter Hanna Jr
SELL
10282 shares
2026-04-16
John Walter Hanna Jr
SELL
19280 shares
2026-01-22
John Walter Hanna Jr
SELL
200 shares
2026-01-21
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 55 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$142 | 56 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 51 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 62 BUY |
Advanced CDNA Option Strategies
Professional options setups generated by AI based on today's CDNA price and gamma walls.
